Ken Griffin Procept Bio Robotics Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 36,400 shares of PRCT stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,400
Previous 53,200
31.58%
Holding current value
$3.02 Million
Previous $2.63 Million
15.44%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PRCT
# of Institutions
214Shares Held
36.3MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$391 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$289 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$150 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$145 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$113 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.7B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...